Navigation Links
200 Pharma Customers to Attend ChemOutsourcing September 17-19, 2013, NJ, USA
Date:8/13/2013

TEANECK, N.J., Aug. 13, 2013 /PRNewswire-iReach/ -- ChemOutsourcing today announced that upwards of 200 Pharma customers from large, small, emerging, and virtual companies will be on hand at the 2013 show in Long Branch, NJ.   Many of the customers are executive managers at the world's largest companies, like Merck, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline, commented Mark Alexay, the event organizer and President of Apaporis, the company that owns the show.

"This year has also seen increasing numbers of attendees coming from the Biotech hub between Boston and Cambridge, MA", remarked Alexay, "with the close proximity of so many suppliers attending the show a big attractant.  CRO's and CMO's from all over the world attend the show to meet their customers;  Custom chemistry companies supplying API's, intermediates, and starting materials come from over 20 countries in North America, Europe, and Asia. If you work anywhere in the USA it's the best place to meet such a large representation of your supply chain".

The 700-800 attendees for the 2013 show:

http://www.chemoutsourcing.com/attendees.php

The list of exhibitors for the Sept 2013 show:

http://www.chemoutsourcing.com/sponsors.php

Alexay went on to add "We are pleased to see such a variety of smaller pharmaceutical companies attending, too, because they clearly represent the future of the industry.  There are hundreds just in the USA, and with funding on the upswing, many are able to expand their small molecule drug discovery and development efforts. This is a welcome event after a long industry financing drought.  Early stage companies are getting money and this also helps Contract Research Organizations (CRO's) contribute their expertise in Drug Discovery and early stage clinical development."

The list of pharmaceutical companies whose chemists in executive management position attending the show:  http://www.chemoutsourcing.com/popup.php

ChemOutsourcing is an annual Pharma-focused chemistry event that takes place every September at the Jersey Shore.  It attracts medicinal and process chemists from pharmaceutical companies working with CRO's and CMO's  striving to bring new human therapeutics to market. www.chemoutsourcing.com

Media Contact: mark alexay, apaporis, llc, 201-452-4023, malexay@chemoutsourcing.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Apaporis, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2013 Results
2. Robbins Arroyo LLP Is Investigating the Directors and Officers of Navidea Biopharmaceuticals, Inc.
3. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
4. AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
5. PipelineRx Announces Telepharmacy Contract with GNYHA Services
6. Emdeon Continues Focus on Patient-Centered Healthcare Solutions; Renews Chain Drug Consortium Contract for Multiple Pharmacy Solutions
7. ANI Pharmaceuticals Announces an Agreement for the Development and Marketing of an Oral Soft Gel Prescription Product with Sofgen Pharmaceuticals
8. Valeant Pharmaceuticals Announces Continuance
9. Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results
10. Ohr Pharmaceutical to Present at the Wedbush Life Sciences Management Access Conference on August 14th
11. ANI Pharmaceuticals Reports Net Revenues of $6.2 million and adjusted non-GAAP EBITDA of $1.2 Million for the Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 10, 2016 CERS ), Medivation, Inc. ... ) and Celldex Therapeutics, Inc. (NASDAQ: CLDX ). ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Orphan Drug Designations become vitally important in the development of ... drugs and biologics which are defined as those intended for ...
(Date:2/10/2016)... /PRNewswire/ - The President of New Venture Medical, ... an anti-radiation product from their Research and Development ... treatment of cancer using radiation and the treating ... the healing of radiation burns, even when open ... the healthy cells from radiation damage. It selectively ...
(Date:2/10/2016)... , Feb. 10, 2016  Silicon Biosystems Menarini ... products that help uncover the biological complexities of ... Inc., a developer of innovative technologies for genomics ... partnership aimed at enabling translational researchers to obtain ... couple hundred tumor and normal cells in an ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 10, 2016 , ... Everseat has joined the award-winning Allscripts ... physicians. The integration will enable Allscripts users to post open appointments to the ... app. , The partnership gives Everseat substantial added power to help Allscripts meet ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Anxiety of older ... the start of Medicare Part D a decade ago, according to The Senior ... older adults on how they are coping with rapidly rising costs. “The implications ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
(Date:2/10/2016)... ... February 10, 2016 , ... It’s that time of year when most ... of the Interscholastic Athletic Association of Maryland (IAAM), Hall of Fame athlete and Garrison ... are cast aside. , That’s why one of her first decisions when her IAAM ...
Breaking Medicine News(10 mins):